Publications in collaboration with researchers from Hospital Clínico San Carlos de Madrid (17)

2024

  1. Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry

    Gastric Cancer, Vol. 27, Núm. 1, pp. 131-145

  2. Prospective study of predictors for anxiety, depression, and somatization in a sample of 1807 cancer patients

    Scientific reports, Vol. 14, Núm. 1, pp. 3188

2023

  1. Coping strategies as mediators of uncertainty and psychological distress in patients with advanced cancer

    Psycho-Oncology, Vol. 32, Núm. 11, pp. 1694-1701

  2. Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 7, pp. 4077-4089

  3. Mental Adjustment, Functional Status, and Depression in Advanced Cancer Patients

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 4

  4. The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

    Therapeutic Advances in Medical Oncology, Vol. 15

  5. The Role of Financial Difficulties as a Mediator between Physical Symptoms and Depression in Advanced Cancer Patients

    Current Oncology, Vol. 30, Núm. 6, pp. 5719-5726

2022

  1. Dignity and psychosocial related variables in elderly advanced cancer patients

    BMC Geriatrics, Vol. 22, Núm. 1

  2. External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study

    Neuroendocrinology, Vol. 112, Núm. 1, pp. 88-100

  3. Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry

    ESMO Open, Vol. 7, Núm. 3

2021

  1. Ascertaining breast cancer patient experiences through a journey map: A qualitative study protocol

    PLoS ONE, Vol. 15, Núm. 12 December

  2. Breast cancer patient experiences through a journey map: A qualitative study

    PLoS ONE, Vol. 16, Núm. 9 September

  3. Correction to: Optimism and social support as contributing factors to spirituality in Cancer patients (Supportive Care in Cancer, (2021), 29, 6, (3367-3373), 10.1007/s00520-020-05954-4)

    Supportive Care in Cancer

  4. Multidimensional Scale of Perceived Social Support (MSPSS) in Cancer Patients: Psychometric Properties and Measurement Invariance

    Psicothema, Vol. 33, Núm. 1, pp. 131-138

  5. Optimism and social support as contributing factors to spirituality in Cancer patients

    Supportive Care in Cancer, Vol. 29, Núm. 6, pp. 3367-3373

  6. Real-life use of ramucirumab in gastric cancer in Spain: The RAMIS study

    Future Oncology, Vol. 17, Núm. 14, pp. 1777-1791

2019

  1. Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis

    Oncologist, Vol. 24, Núm. 8, pp. e687-e695